132 related articles for article (PubMed ID: 17179718)
1. New-onset Tourette syndrome following human growth hormone therapy.
Doneray H; Tan H; Orbak Z
Eur Neurol; 2007; 57(2):116-7. PubMed ID: 17179718
[No Abstract] [Full Text] [Related]
2. Pavor nocturnus as a side effect of a single daily risperidone dose.
Prueter C; Luecke FG; Hoff P
Gen Hosp Psychiatry; 2005; 27(4):300-1. PubMed ID: 15993264
[No Abstract] [Full Text] [Related]
3. Advances in pediatric growth hormone therapy: IGF-I-based dosing.
Pawlikowska-Haddal A; Cohen P
Indian Pediatr; 2006 Jul; 43(7):577-81. PubMed ID: 16891676
[No Abstract] [Full Text] [Related]
4. Is growth hormone just a tall story?
Rosenfeld RG
J Pediatr; 1997 Feb; 130(2):172-4. PubMed ID: 9042114
[No Abstract] [Full Text] [Related]
5. [Kearns-Sayre syndrome associated with growth hormone deficiency].
De Sanctis V; Calzolari F; Piazzi A; Berio A
Pediatr Med Chir; 2003; 25(6):447-51. PubMed ID: 15279371
[TBL] [Abstract][Full Text] [Related]
6. Individualization of growth hormone therapy.
Johnston LB
Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):517-24. PubMed ID: 18538290
[TBL] [Abstract][Full Text] [Related]
7. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
Westphal O; Lindberg A;
Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
[TBL] [Abstract][Full Text] [Related]
8. Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome.
Degrauw RS; Li JZ; Gilbert DL
Pediatr Neurol; 2009 Sep; 41(3):183-6. PubMed ID: 19664533
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
Peterkova V; Arslanoglu I; Bolshova-Zubkovskaya E; Romer T; Zdravkovic D; Kratzsch J; Ji HJ; Savoy C; Saenger P
Horm Res; 2007; 68(6):288-93. PubMed ID: 17627092
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic short stature: management and growth hormone treatment.
Wit JM; Reiter EO; Ross JL; Saenger PH; Savage MO; Rogol AD; Cohen P
Growth Horm IGF Res; 2008 Apr; 18(2):111-35. PubMed ID: 18178498
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Moore WV; Dana K; Frane J; Lippe B
Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
[TBL] [Abstract][Full Text] [Related]
12. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone therapy for short children born small for gestational age.
Chatelain P; Carrascosa A; Bona G; Ferrandez-Longas A; Sippell W
Horm Res; 2007; 68(6):300-9. PubMed ID: 17823537
[TBL] [Abstract][Full Text] [Related]
15. Growth and growth hormone treatment in short stature children born small for gestational age.
Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
[TBL] [Abstract][Full Text] [Related]
16. Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.
Simon D; Léger J; Carel JC
Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):525-37. PubMed ID: 18538291
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone: brain haemorrhage.
Prescrire Int; 2015 Apr; 24(159):98. PubMed ID: 25941705
[No Abstract] [Full Text] [Related]
18. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
Cutfield WS; Lundgren F
Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
[TBL] [Abstract][Full Text] [Related]
19. A tale of two centimeters.
Rosenfeld RG
J Pediatr; 2005 Jan; 146(1):10-1. PubMed ID: 15644813
[No Abstract] [Full Text] [Related]
20. Tourette syndrome.
Jimenez-Shahed J
Neurol Clin; 2009 Aug; 27(3):737-55, vi. PubMed ID: 19555829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
